Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2505078-08-8
2. Blu-263
3. 6fbm4cp6rk
4. Blu263
5. Exampl4 4 [wo2020210293a1]
6. 1h-pyrazole-1-ethanol, 4-(4-(4-(5-((1s)-1-amino-1-(4-fluorophenyl)ethyl)-2-pyrimidinyl)-1-piperazinyl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)-
7. 2-[4-[4-[4-[5-[(1s)-1-amino-1-(4-fluorophenyl)ethyl]pyrimidin-2-yl]piperazin-1-yl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]pyrazol-1-yl]ethanol
8. 1h-pyrazole-1-ethanol, 4-[4-[4-[5-[(1s)-1-amino-1-(4-fluorophenyl)ethyl]-2-pyrimidinyl]-1-piperazinyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]-
9. 4-[4-[4-[5-[(1s)-1-amino-1-(4-fluorophenyl)ethyl]-2-pyrimidinyl]-1-piperazinyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1h-pyrazole-1-ethanol
10. Exampl4 4 (wo2020210293a1)
11. 2-(4-(4-(4-(5-((1s)-1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)-1h-pyrazol-1-yl)ethan-1-ol
12. 2-(4-(4-(4-(5-((1s)-1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)pyrazol-1-yl)ethanol
13. 2-{4-[4-(4-{5-[(1s)-1-amino-1-(4-fluorophenyl)ethyl]pyrimidin-2-yl}piperazin-1-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1h-pyrazol-1-yl}ethan-1-ol
14. 4-(4-(4-(5-((1s)-1-amino-1-(4-fluorophenyl)ethyl)-2-pyrimidinyl)-1-piperazinyl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)-1h-pyrazole-1-ethanol
15. Refchem:136476
16. Blu 263
17. D816v-mutant Kit Inhibitor Blu-263
18. Kit D816v Mutant-selective Inhibitor Blu-263
19. Elenestinib [usan]
20. Unii-6fbm4cp6rk
21. Who 12608
22. Elenestinib (usan)
23. (s)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl)-1h-pyrazol-1-yl)ethan-1-ol
24. (s)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo(2,1-f)(1,2,4)triazin-6-yl)-1h-pyrazol-1-yl)ethan-1-ol
25. Elenestinib [inn]
26. Elenestinib(blu-263)
27. Orb1298206
28. Chembl5314552
29. Schembl22527434
30. Gtpl12357
31. Glxc-26842
32. Ex-a4620
33. At32812
34. Ac-37128
35. Da-73060
36. Ms-29783
37. Hy-152839
38. Cs-0641116
39. D12450
40. 2-{4-[4-(4-{5-[(1s)-1-amino-1-(4- Fluorophenyl)ethyl]pyrimidin-2-yl}piperazin-1- Yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1h-pyrazol-1- Yl}ethan-1-ol
| Molecular Weight | 528.6 g/mol |
|---|---|
| Molecular Formula | C27H29FN10O |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 127 |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 789 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
63
PharmaCompass offers a list of Elenestinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Elenestinib manufacturer or Elenestinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Elenestinib manufacturer or Elenestinib supplier.
A Elenestinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elenestinib, including repackagers and relabelers. The FDA regulates Elenestinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elenestinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Elenestinib supplier is an individual or a company that provides Elenestinib active pharmaceutical ingredient (API) or Elenestinib finished formulations upon request. The Elenestinib suppliers may include Elenestinib API manufacturers, exporters, distributors and traders.
Elenestinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elenestinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Elenestinib GMP manufacturer or Elenestinib GMP API supplier for your needs.
A Elenestinib CoA (Certificate of Analysis) is a formal document that attests to Elenestinib's compliance with Elenestinib specifications and serves as a tool for batch-level quality control.
Elenestinib CoA mostly includes findings from lab analyses of a specific batch. For each Elenestinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elenestinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Elenestinib EP), Elenestinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elenestinib USP).
